The study also met a secondary goal of preventing cancer from spreading to different parts of the body.

Personalized Cancer Vaccines Mark a New Era in Precision Immunotherapy / cancer, cancer immunotherapy, cancer vaccines, DMFS, ...

The announcement by Moderna Inc. and Merck & Co. that a messenger RNA-based cancer vaccine had lowered the recurrence rate ...

The companies said their vaccine helped prevent the return and spread of melanoma in a trial that involved more than 1,000 ...

Moderna shares surged more than 170 percent in a single session after a personalized messenger RNA cancer vaccine ...

Dr. Michael Postow, chief of the melanoma service at Memorial Sloan Kettering Cancer Center, breaks down the new personalized ...

Senator Malcolm Roberts caused 'outage' when he asked questions about Australia's miscarriage statistics - but were his ...

Firstpost brings out an expert’s view on the growing link between obesity and cancer, how excess body fat may increase cancer ...

It was given to patients with high-risk melanoma - the most aggressive form of skin cancer causing about 2,600 deaths a year ...

Noubar Afeyan on Moderna and Merck’s Phase 3 INTerpath-001 Results: “It Was a Déjà Vu Moment” / cancer, INTerpath-001 trial, ...

The next generation of mRNA medicines – including vaccines fighting against infectious disease, cancer and autoimmune ...

After years of layoffs, cash burn and political attacks on its core technology, Moderna’s melanoma vaccine data notched the ...